PGEN Precigen Inc

Price (delayed)

$7.51

Market cap

$1.54B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.02

Enterprise value

$1.68B

Sector: Healthcare
Industry: Biotechnology

Highlights

PGEN's gross profit has surged by 63% year-on-year and by 9% since the previous quarter
Precigen's EPS has surged by 51% YoY and by 46% QoQ
PGEN's equity is up by 15% since the previous quarter but it is down by 6% year-on-year
PGEN's quick ratio is down by 36% from the previous quarter

Key stats

What are the main financial stats of PGEN
Market
Shares outstanding
205.66M
Market cap
$1.54B
Enterprise value
$1.68B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
20.73
Price to sales (P/S)
12.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.23
Earnings
Revenue
$103.18M
EBIT
-$152.2M
EBITDA
-$134.69M
Free cash flow
-$78.06M
Per share
EPS
-$1.02
Free cash flow per share
-$0.47
Book value per share
$0.36
Revenue per share
$0.62
TBVPS
$1.17
Balance sheet
Total assets
$314.59M
Total liabilities
$247.41M
Debt
$182.28M
Equity
$67.17M
Working capital
$106.82M
Liquidity
Debt to equity
2.71
Current ratio
3.54
Quick ratio
2.77
Net debt/EBITDA
-0.97
Margins
EBITDA margin
-130.5%
Gross margin
46.2%
Net margin
-165.3%
Operating margin
-84.1%
Efficiency
Return on assets
-48.1%
Return on equity
-259.8%
Return on invested capital
-41.8%
Return on capital employed
-55.9%
Return on sales
-147.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGEN stock price

How has the Precigen stock price performed over time
Intraday
0.27%
1 week
9.96%
1 month
-8.3%
1 year
155.44%
YTD
-26.37%
QTD
9%

Financial performance

How have Precigen's revenue and profit performed over time
Revenue
$103.18M
Gross profit
$47.67M
Operating income
-$86.77M
Net income
-$170.52M
Gross margin
46.2%
Net margin
-165.3%
PGEN's gross profit has surged by 63% year-on-year and by 9% since the previous quarter
PGEN's operating margin has soared by 53% YoY and by 34% from the previous quarter
Precigen's net margin has soared by 53% YoY and by 44% from the previous quarter
PGEN's net income is up by 47% year-on-year and by 43% since the previous quarter

Growth

What is Precigen's growth rate over time

Valuation

What is Precigen stock price valuation
P/E
N/A
P/B
20.73
P/S
12.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.23
Precigen's EPS has surged by 51% YoY and by 46% QoQ
PGEN's P/B is 200% above its 5-year quarterly average of 6.9 and 33% above its last 4 quarters average of 15.6
PGEN's equity is up by 15% since the previous quarter but it is down by 6% year-on-year
PGEN's P/S is 33% above its last 4 quarters average of 9.1 and 17% above its 5-year quarterly average of 10.4
Precigen's revenue has increased by 14% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Precigen business performance
PGEN's return on equity has dropped by 80% year-on-year but it is up by 42% since the previous quarter
Precigen's return on sales has surged by 56% YoY and by 47% QoQ
The ROIC has grown by 42% from the previous quarter and by 34% YoY
The ROA has grown by 37% from the previous quarter and by 10% YoY

Dividends

What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGEN.

Financial health

How did Precigen financials performed over time
The company's total assets is 27% higher than its total liabilities
PGEN's current ratio has surged by 85% year-on-year but it is down by 28% since the previous quarter
PGEN's quick ratio is down by 36% from the previous quarter
Precigen's debt is 171% more than its equity
PGEN's debt to equity is down by 28% from the previous quarter and by 16% YoY
Precigen's debt has decreased by 22% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.